Takeda Planning Japan Approval Application For Multiple Sclerosis Drug Developed By Teva
This article was originally published in PharmAsia News
Executive Summary
Takeda has signed a license agreement in the first half of 2013 to commercialize glatiramer acetate, an injectable agent for multiple sclerosis treatment, in Japan.